Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Glaukos Corporation    GKOS

GLAUKOS CORPORATION

(GKOS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

GLAUKOS CORP : Other Events, Financial Statements and Exhibits (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
01/15/2020 | 07:06am EST

Item 8.01. Other Events.

Glaukos Corporation (the "Company") intends to present the materials attached as Exhibit 99.1 to this Current Report on Form 8-K (the "Investor Presentation") from time to time in presentations to investors and other stakeholders. The Investor Presentation will also be available on the investor page of the Company's website at http://investors.glaukos.com.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.




Exhibit No.    Description
99.1             Investor Presentation, dated January 2020
               Cover Page Interactive Data File (embedded within the Inline XBRL
104            document)

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on GLAUKOS CORPORATION
02/06GLAUKOS CORPORATION : to Release Fourth Quarter and Full Year 2019 Financial Res..
BU
02/05GLAUKOS : Financial Statements and Exhibits (form 8-K/A)
AQ
01/15GLAUKOS CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
01/03GLAUKOS : Announces Participation in J.P. Morgan Healthcare Conference
BU
2019GLAUKOS CORP : Completion of Acquisition or Disposition of Assets, Regulation FD..
AQ
2019GLAUKOS : Completes Acquisition of Avedro, Inc.
BU
2019GLAUKOS : Announces Participation in Piper Jaffray Healthcare Conference
BU
2019GLAUKOS CORP : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
2019GLAUKOS : 3Q Earnings Snapshot
AQ
2019GLAUKOS : Management's Discussion and Analysis of Financial Condition and Result..
AQ
More news
Financials (USD)
Sales 2019 241 M
EBIT 2019 -26,2 M
Net income 2019 -28,3 M
Finance 2019 96,5 M
Yield 2019 -
P/E ratio 2019 -90,6x
P/E ratio 2020 -119x
EV / Sales2019 11,4x
EV / Sales2020 8,70x
Capitalization 2 838 M
Chart GLAUKOS CORPORATION
Duration : Period :
Glaukos Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GLAUKOS CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 67,13  $
Last Close Price 65,50  $
Spread / Highest target 22,1%
Spread / Average Target 2,48%
Spread / Lowest Target -13,0%
EPS Revisions
Managers
NameTitle
Thomas William Burns President, Chief Executive Officer & Director
William J. Link Chairman
Chris M. Calcaterra Chief Operating Officer
Joseph E. Gilliam CFO, CAO & Senior VP-Corporate Development
L. Jay Katz Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
GLAUKOS CORPORATION23.65%2 918
STRYKER CORPORATION7.22%84 317
SMITH & NEPHEW PLC0.68%20 863
WRIGHT MEDICAL GROUP N.V.-0.10%3 914
INSPIRE MEDICAL SYSTEMS, INC.10.38%1 917
AXONICS MODULATION TECHNOLOGIES, INC.26.34%1 190